Beste Dany J V, Nöh Katharina, Niedenführ Sebastian, Mendum Tom A, Hawkins Nathaniel D, Ward Jane L, Beale Michael H, Wiechert Wolfgang, McFadden Johnjoe
Department of Microbial and Cellular Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.
Chem Biol. 2013 Aug 22;20(8):1012-21. doi: 10.1016/j.chembiol.2013.06.012. Epub 2013 Aug 1.
Whereas intracellular carbon metabolism has emerged as an attractive drug target, the carbon sources of intracellularly replicating pathogens, such as the tuberculosis bacillus Mycobacterium tuberculosis, which causes long-term infections in one-third of the world's population, remain mostly unknown. We used a systems-based approach--(13)C-flux spectral analysis (FSA) complemented with manual analysis-to measure the metabolic interaction between M. tuberculosis and its macrophage host cell. (13)C-FSA analysis of experimental data showed that M. tuberculosis obtains a mixture of amino acids, C1 and C2 substrates from its host cell. We experimentally confirmed that the C1 substrate was derived from CO2. (13)C labeling experiments performed on a phosphoenolpyruvate carboxykinase mutant revealed that intracellular M. tuberculosis has access to glycolytic C3 substrates. These findings provide constraints for developing novel chemotherapeutics.
鉴于细胞内碳代谢已成为一个有吸引力的药物靶点,但细胞内复制病原体的碳源,如导致世界三分之一人口长期感染的结核杆菌结核分枝杆菌,大多仍不为人知。我们采用了一种基于系统的方法——(13)C通量光谱分析(FSA)并辅以人工分析——来测量结核分枝杆菌与其巨噬细胞宿主细胞之间的代谢相互作用。对实验数据的(13)C-FSA分析表明,结核分枝杆菌从其宿主细胞中获得氨基酸、C1和C2底物的混合物。我们通过实验证实C1底物来源于二氧化碳。对磷酸烯醇式丙酮酸羧激酶突变体进行的(13)C标记实验表明,细胞内的结核分枝杆菌可以利用糖酵解产生的C3底物。这些发现为开发新型化疗药物提供了限制条件。